Formulation aspects in the development of osmotically controlled oral drug delivery systems
- PMID: 11853915
- DOI: 10.1016/s0168-3659(01)00550-8
Formulation aspects in the development of osmotically controlled oral drug delivery systems
Abstract
Osmotically controlled oral drug delivery systems utilize osmotic pressure for controlled delivery of active agent(s). Drug delivery from these systems, to a large extent, is independent of the physiological factors of the gastrointestinal tract and these systems can be utilized for systemic as well as targeted delivery of drugs. The release of drug(s) from osmotic systems is governed by various formulation factors such as solubility and osmotic pressure of the core component(s), size of the delivery orifice, and nature of the rate-controlling membrane. By optimizing formulation and processing factors, it is possible to develop osmotic systems to deliver drugs of diverse nature at a pre-programmed rate. In the present review, different types of oral osmotic systems, various aspects governing drug release from these systems, and critical formulation factors are discussed.
Similar articles
-
Osmotically controlled oral drug delivery.Drug Dev Ind Pharm. 2000 Jul;26(7):695-708. doi: 10.1081/ddc-100101287. Drug Dev Ind Pharm. 2000. PMID: 10872087 Review.
-
[Osmotically controlled oral drug delivery systems: an update review].Zhongguo Zhong Yao Za Zhi. 2008 Mar;33(5):598-602. Zhongguo Zhong Yao Za Zhi. 2008. PMID: 18536389 Review. Chinese.
-
An overview of recent patents on oral osmotic drug delivery systems.Recent Pat Drug Deliv Formul. 2007;1(3):236-55. doi: 10.2174/187221107782331638. Recent Pat Drug Deliv Formul. 2007. PMID: 19075891 Review.
-
Osmotic pumps in drug delivery.Crit Rev Ther Drug Carrier Syst. 2004;21(6):477-520. doi: 10.1615/critrevtherdrugcarriersyst.v21.i6.20. Crit Rev Ther Drug Carrier Syst. 2004. PMID: 15658934 Review.
-
Osmotically controlled drug delivery system with associated drugs.J Pharm Pharm Sci. 2010;13(4):571-88. doi: 10.18433/j38w25. J Pharm Pharm Sci. 2010. PMID: 21486532 Review.
Cited by
-
Implantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications.Polymers (Basel). 2018 Dec 12;10(12):1379. doi: 10.3390/polym10121379. Polymers (Basel). 2018. PMID: 30961303 Free PMC article. Review.
-
Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.Pharmaceutics. 2010 May 18;2(2):199-208. doi: 10.3390/pharmaceutics2020199. Pharmaceutics. 2010. PMID: 27721351 Free PMC article.
-
Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate.Res Pharm Sci. 2016 Jan-Feb;11(1):81-92. Res Pharm Sci. 2016. PMID: 27051436 Free PMC article.
-
Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine.CPT Pharmacometrics Syst Pharmacol. 2024 Feb;13(2):247-256. doi: 10.1002/psp4.13075. Epub 2023 Dec 21. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38130031 Free PMC article.
-
Osmolality of Excipients for Parenteral Formulation Measured by Freezing Point Depression and Vapor Pressure - A Comparative Analysis.Pharm Res. 2023 Jul;40(7):1709-1722. doi: 10.1007/s11095-022-03262-6. Epub 2022 Apr 22. Pharm Res. 2023. PMID: 35460023
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources